Quiet is Good!A gentle bump in the sp on low volumes and a move to a 24% BUY from a week of weak sell on Barchart. Morningstar's Fair Value sp continues to hover in and around $.50 and rapid antigen testing continues to be front and centre in the news. The following from Europe today where covid rates are going up, particularly in the unvaccinated, and individuals will no longer receive free tests. This would be a great time for THRM to start manufacturing its inexpensive, accurate, easy to use alternative, AcuVid ...that already has its CE mark for Europe.
https://www.schengenvisainfo.com/news/these-3-eu-schengen-countries-now-oblige-travellers-to-pay-for-covid-19-tests/ GLTE ...holding patiently!!! Hopefully the cross reactivity testing has already started.